Drugs in Dev.
Immunology
Phase II
Lithuania 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : IRL201805
Therapeutic Area : Immunology
Study Phase : Phase II
Sponsor : Revolo Biotherapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the agreement, Northway will provide the full scope of its’ services ranging from cell line development to batch production of ‘1805 Active Pharmaceutical Ingredients (API) and drug product, following Current Good Manufacturing Pra...
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
June 09, 2021
Lead Product(s) : IRL201805
Therapeutic Area : Immunology
Highest Development Status : Phase II
Sponsor : Revolo Biotherapeutics
Deal Size : Undisclosed
Deal Type : Agreement
